
CVM
Healthcare · Biotechnology · $22.5M market cap
$1.27+0.08 (+6.7%)Nov 13, 4:00 PM EST
Next report
Time not confirmed
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Jan 4, 2027 · upcoming | Time not confirmed | — | — | — |
| Aug 14, 2026 | Time not confirmed | — | -0.47 | — |
| Feb 12, 2026 | Before the open | 0.00 | -0.68 | — |
| Dec 23, 2025 | After the close | — | -0.86 | — |
| Aug 12, 2025 | After the close | — | -1.36 | — |
| May 13, 2025 | After the close | — | -2.33 | — |
| Jan 13, 2025 | After the close | -3.30 | -2.70 | +18.2% |
| Dec 31, 2024 | Time not confirmed | -0.10 | -2.70 | -2600.3% |
| Aug 14, 2024 | After the close | -3.90 | -4.20 | -7.7% |
| May 15, 2024 | After the close | -4.20 | -8.40 | -100.0% |
| Feb 14, 2024 | After the close | -4.20 | -4.20 | 0.0% |
| Dec 21, 2023 | After the close | -0.16 | -0.16 | 0.0% |
| Aug 11, 2023 | Before the open | -4.50 | -5.70 | -26.7% |
CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain head and neck cancers. It is also developing Ligand Epitope Antigen Presentation System (LEAPS)…
| May 12, 2023 | After the close | -5.10 | -5.70 | -11.8% |
| Feb 14, 2023 | After the close | -3.00 | -5.40 | -80.0% |
| Dec 27, 2022 | After the close | -0.20 | -0.21 | -5.0% |
| Aug 12, 2022 | After the close | -2.70 | -6.90 | -155.6% |
| May 13, 2022 | After the close | -2.70 | -6.90 | -155.6% |
| Feb 11, 2022 | After the close | -0.19 | -0.20 | -5.3% |
| Dec 21, 2021 | After the close | -3.00 | -5.70 | -90.0% |
| Aug 13, 2021 | After the close | -3.90 | -6.60 | -69.2% |
| May 18, 2021 | Before the open | -5.70 | -8.40 | -47.4% |
| Feb 12, 2021 | After the close | -0.15 | -0.21 | -40.0% |
| Dec 29, 2020 | After the close | -3.00 | -4.20 | -40.0% |
| Aug 10, 2020 | After the close | -5.70 | -8.10 | -42.1% |
| May 11, 2020 | Before the open | -4.50 | -7.50 | -66.7% |
| Feb 10, 2020 | Before the open | -0.15 | -0.16 | -6.7% |
| Dec 16, 2019 | After the close | -2.70 | -3.90 | -44.4% |
| Aug 14, 2019 | After the close | -3.00 | -11.10 | -270.0% |
| May 14, 2019 | After the close | -0.12 | -0.22 | -83.3% |
| Feb 14, 2019 | After the close | — | 0.04 | — |
| Dec 19, 2018 | After the close | — | -0.67 | — |
| Aug 14, 2018 | After the close | — | -0.36 | — |
| May 15, 2018 | After the close | — | -0.31 | — |
| Feb 12, 2018 | After the close | — | -0.53 | — |